AURORA CANNABIS INC (ACB) Form 6-K — Nov 3, 2026
Aurora Cannabis has agreed to be acquired by Organigram Global for C$7.80 per share in a deal valuing Aurora at roughly C$561 million on a fully diluted basis, ending a months-long battle that included a rejected hostile bid from Curaleaf. Aurora shareholders can elect cash, 5.8626 Organigram shares, or a mix of C$3.75 plus 3.0431 Organigram shares, subject to proration. The price represents a 93% premium to Aurora's unaffected share price from August 10, 2026, and a 21% premium to the value of Curaleaf's hostile offer, which the Aurora board continues to recommend shareholders reject.
Key figures
- Deal Value Usd
- C$561 million (fully diluted equity value, ~USD equivalent not stated)
- Expected closing
- January 2027
- Special meetings
- December 2026
- Max cash pool cad
- 253638772
- Per share price cad
- C$7.80
- Share exchange ratio
- 5.8626 Organigram shares per Aurora share
- Max ogt shares issued
- 205826172
- Combined consideration
- C$3.75 cash + 3.0431 Organigram shares per Aurora share
- Atb loan facilities usd
- 210000000
- Identified synergies cad
- C$50 million+
- Bat private placement cad
- C$187.5 million (141.0 million Organigram shares at C$1.33)
- Aurora pro forma ownership
- ~35% economic / 42% voting
- Premium to unaffected price
- 93% (vs August 10, 2026)
- Premium to curaleaf hostile bid
- 21%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.